
MintNeuro
MintNeuro designs purpose-built, ultra-low-power semiconductor chips for neural devices, enabling smaller, safer, and more scalable implants and wearables. Their modular chip platform supports neural signal acquisition, electrical stimulation, on-chip processing, and wireless data transfer for applications from epilepsy monitoring to brain-computer interfaces. The company works with medical device firms and researchers to integrate these chips into minimally invasive neural technologies.
- Semiconductor
- Medical Devices
- Healthcare Technology
- Hardware
- Biotechnology
Funding
Raised to date
$6.3MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
across 2 rounds




EH+6$5M · Seed
Announced Oct 2026 · from article date
Disclosed cumulative: $6.3M
Founders
Timothy Constandinou
Co-founder
Product
Problem
Current neural implants for treating neurological conditions often require invasive surgical procedures due to their size and complexity. These implants also have limited capabilities in sensing, processing, and modulating neural activity, hindering effective treatment and monitoring of neurological disorders.
Solution
MintNeuro is developing next-generation neural implants utilizing scalable semiconductor technology to address the limitations of existing solutions. Their compact, low-power bioelectronic implants enable minimally invasive procedures, reducing patient risk and improving accessibility. By focusing on advanced integrated circuits, MintNeuro's technology facilitates high-performance sensing, processing, and modulation of neural activity. The company's modular chiplet approach allows for customized solutions that can be efficiently combined to address a wide range of neurological conditions, paving the way for more effective and less invasive therapeutic interventions.
Target Audience
MintNeuro's primary target audience includes medical device companies, system integrators building active implantable medical devices (AIMDs) and brain-computer interfaces (BCIs), innovative neurotech companies building wearable devices, and research institutions and clinical groups translating neurotechnologies.
Features
- Ultra-low power integrated circuits engineered for high performance and long-term reliability
- Wireless communication capabilities for seamless data transfer and remote monitoring
- Miniaturized implantable devices designed for minimally invasive surgical procedures
- Modular design using specialized "chiplets" for sensing, stimulation, and processing
- Customizable solutions tailored to specific neurological conditions and patient needs
- Focus on both sensing applications (e.g., epilepsy neuromonitoring, brain-computer interfaces) and neuromodulation
- Development of a "neural chipset" with function-specific chips designed to work together across multiple applications
- On-chip signal processing and data reduction capabilities
- Power management integrated with wireless data transfer
- Designed to regulatory standards of size, power, and safety
- Manufactured through close partnership with trusted foundries
- Scalable from research prototypes to commercial devices